November 4, 2025 at 3:14 PM
May 13, 2025 at 4:17 PM
It's not Friday but no excuse needed to post more cool brain pictures - VTA GAD terminals in rat habenula+midline thalamus #TissueTuesday
September 26, 2023 at 3:17 PM
It's not Friday but no excuse needed to post more cool brain pictures - VTA GAD terminals in rat habenula+midline thalamus #TissueTuesday
Today's #TissueTuesday involves autopsy findings in a sheep:
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in #VetPath to see if you are on the right track!
👉 bit.ly/4gZK2Ai
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in #VetPath to see if you are on the right track!
👉 bit.ly/4gZK2Ai
February 26, 2025 at 3:24 AM
Today's #TissueTuesday involves autopsy findings in a sheep:
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in #VetPath to see if you are on the right track!
👉 bit.ly/4gZK2Ai
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in #VetPath to see if you are on the right track!
👉 bit.ly/4gZK2Ai
Today's #TissueTuesday involves autopsy findings in a cow:
❓ Histopath features
❓ Morphologic diagnosis
❓ Cause
Check out the great case in Vet Path to see if you are on the right track!
👉 bit.ly/4i1Vr3M
❓ Histopath features
❓ Morphologic diagnosis
❓ Cause
Check out the great case in Vet Path to see if you are on the right track!
👉 bit.ly/4i1Vr3M
February 18, 2025 at 3:15 PM
Today's #TissueTuesday involves autopsy findings in a cow:
❓ Histopath features
❓ Morphologic diagnosis
❓ Cause
Check out the great case in Vet Path to see if you are on the right track!
👉 bit.ly/4i1Vr3M
❓ Histopath features
❓ Morphologic diagnosis
❓ Cause
Check out the great case in Vet Path to see if you are on the right track!
👉 bit.ly/4i1Vr3M
Today's #TissueTuesday involves autopsy findings in a wild felid:
❓ Histopath features
❓ Morphologic diagnosis
❓ Likely species
❓ Other possible location(s)
Check out the interesting Q&A in #VetPath!
👉 bit.ly/49crc6e
👉 bit.ly/3HS5DLU
❓ Histopath features
❓ Morphologic diagnosis
❓ Likely species
❓ Other possible location(s)
Check out the interesting Q&A in #VetPath!
👉 bit.ly/49crc6e
👉 bit.ly/3HS5DLU
April 15, 2025 at 3:18 PM
Today's #TissueTuesday involves autopsy findings in a wild felid:
❓ Histopath features
❓ Morphologic diagnosis
❓ Likely species
❓ Other possible location(s)
Check out the interesting Q&A in #VetPath!
👉 bit.ly/49crc6e
👉 bit.ly/3HS5DLU
❓ Histopath features
❓ Morphologic diagnosis
❓ Likely species
❓ Other possible location(s)
Check out the interesting Q&A in #VetPath!
👉 bit.ly/49crc6e
👉 bit.ly/3HS5DLU
Today's #TissueTuesday involves clinical findings in a rabbit:
❓ Associated lesion
Check out the entire case in #VetPath via the Q&A links below!
👉Q: bit.ly/4kX8eWm
👉A: bit.ly/4ndwxld
❓ Associated lesion
Check out the entire case in #VetPath via the Q&A links below!
👉Q: bit.ly/4kX8eWm
👉A: bit.ly/4ndwxld
June 10, 2025 at 6:45 PM
Today's #TissueTuesday involves clinical findings in a rabbit:
❓ Associated lesion
Check out the entire case in #VetPath via the Q&A links below!
👉Q: bit.ly/4kX8eWm
👉A: bit.ly/4ndwxld
❓ Associated lesion
Check out the entire case in #VetPath via the Q&A links below!
👉Q: bit.ly/4kX8eWm
👉A: bit.ly/4ndwxld
Today's #TissueTuesday involves autopsy findings in the brain and spinal cord of a dog:
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in the Jan 2025 issue of Vet Path to see if you are on the right track!
👉 bit.ly/4h2zCk1
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in the Jan 2025 issue of Vet Path to see if you are on the right track!
👉 bit.ly/4h2zCk1
March 4, 2025 at 8:51 PM
Today's #TissueTuesday involves autopsy findings in the brain and spinal cord of a dog:
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in the Jan 2025 issue of Vet Path to see if you are on the right track!
👉 bit.ly/4h2zCk1
❓ Histopath features
❓ Morphologic diagnosis
❓ Differentials
Check out the great case in the Jan 2025 issue of Vet Path to see if you are on the right track!
👉 bit.ly/4h2zCk1
Today's #TissueTuesday involves autopsy findings in a cow:
❓ Histopath features
❓ Location
❓ Morphologic diagnosis
❓ Useful IHC
Follow the link below to read the article in #VetPath:
👉 bit.ly/3YcLGrY
❓ Histopath features
❓ Location
❓ Morphologic diagnosis
❓ Useful IHC
Follow the link below to read the article in #VetPath:
👉 bit.ly/3YcLGrY
April 22, 2025 at 8:31 PM
Today's #TissueTuesday involves autopsy findings in a cow:
❓ Histopath features
❓ Location
❓ Morphologic diagnosis
❓ Useful IHC
Follow the link below to read the article in #VetPath:
👉 bit.ly/3YcLGrY
❓ Histopath features
❓ Location
❓ Morphologic diagnosis
❓ Useful IHC
Follow the link below to read the article in #VetPath:
👉 bit.ly/3YcLGrY
Today's #TissueTuesday involves biopsy findings in the subcutis of a dog:
❓ Histopath features
❓ Origin
Check out the link below to the case in Jan 2023 Vet Path, to see if you are on the right track!
👉 bit.ly/427gJ9T
❓ Histopath features
❓ Origin
Check out the link below to the case in Jan 2023 Vet Path, to see if you are on the right track!
👉 bit.ly/427gJ9T
March 25, 2025 at 6:12 PM
Today's #TissueTuesday involves biopsy findings in the subcutis of a dog:
❓ Histopath features
❓ Origin
Check out the link below to the case in Jan 2023 Vet Path, to see if you are on the right track!
👉 bit.ly/427gJ9T
❓ Histopath features
❓ Origin
Check out the link below to the case in Jan 2023 Vet Path, to see if you are on the right track!
👉 bit.ly/427gJ9T
Today's #TissueTuesday involves autopsy findings in a rhesus macaque:
❓ Location
❓ Histopath features
❓ Cause
Follow the links below to see the case in #VetPath:
Q: 👉 bit.ly/46RMWTW
A: 👉 bit.ly/46LpdEV
❓ Location
❓ Histopath features
❓ Cause
Follow the links below to see the case in #VetPath:
Q: 👉 bit.ly/46RMWTW
A: 👉 bit.ly/46LpdEV
May 20, 2025 at 3:16 PM
Today's #TissueTuesday involves autopsy findings in a rhesus macaque:
❓ Location
❓ Histopath features
❓ Cause
Follow the links below to see the case in #VetPath:
Q: 👉 bit.ly/46RMWTW
A: 👉 bit.ly/46LpdEV
❓ Location
❓ Histopath features
❓ Cause
Follow the links below to see the case in #VetPath:
Q: 👉 bit.ly/46RMWTW
A: 👉 bit.ly/46LpdEV
Today's #TissueTuesday involves biopsy findings in a dog:
❓ Location
❓ Key histopath features
❓ Differentials
❓ Useful IHC
Check out the link below to the case in Vet Path, to see if you are on the right track!
👉 bit.ly/4275w93
❓ Location
❓ Key histopath features
❓ Differentials
❓ Useful IHC
Check out the link below to the case in Vet Path, to see if you are on the right track!
👉 bit.ly/4275w93
April 1, 2025 at 3:04 PM
Today's #TissueTuesday involves biopsy findings in a dog:
❓ Location
❓ Key histopath features
❓ Differentials
❓ Useful IHC
Check out the link below to the case in Vet Path, to see if you are on the right track!
👉 bit.ly/4275w93
❓ Location
❓ Key histopath features
❓ Differentials
❓ Useful IHC
Check out the link below to the case in Vet Path, to see if you are on the right track!
👉 bit.ly/4275w93
#TissueTuesday
Proteintech’s MLH1 Monoclonal Antibody is derived from a clone optimized for high performance in IHC. It has been validated in multiple cancer tissues with whole slide images provided for the most in-depth look at IHC data.
Learn more: https://bit.ly/4jgp0Cg
Proteintech’s MLH1 Monoclonal Antibody is derived from a clone optimized for high performance in IHC. It has been validated in multiple cancer tissues with whole slide images provided for the most in-depth look at IHC data.
Learn more: https://bit.ly/4jgp0Cg
MLH1 antibody (60822-2-Ig) | Proteintech
Proteintech's Mouse Monoclonal MLH1 antibody is validated in IHC, ELISA and shows reactivity with human samples.
bit.ly
September 22, 2026 at 3:48 PM
#TissueTuesday
Proteintech’s MLH1 Monoclonal Antibody is derived from a clone optimized for high performance in IHC. It has been validated in multiple cancer tissues with whole slide images provided for the most in-depth look at IHC data.
Learn more: https://bit.ly/4jgp0Cg
Proteintech’s MLH1 Monoclonal Antibody is derived from a clone optimized for high performance in IHC. It has been validated in multiple cancer tissues with whole slide images provided for the most in-depth look at IHC data.
Learn more: https://bit.ly/4jgp0Cg
#TissueTuesday
Our TROP2 Recombinant Antibody can be used to map TROP2 expression in breast and other cancer types through IHC, helping you to predict potential responses to targeted therapies.
Learn more: https://bit.ly/3U6YlO3
Our TROP2 Recombinant Antibody can be used to map TROP2 expression in breast and other cancer types through IHC, helping you to predict potential responses to targeted therapies.
Learn more: https://bit.ly/3U6YlO3
August 25, 2026 at 5:58 PM
#TissueTuesday
Our TROP2 Recombinant Antibody can be used to map TROP2 expression in breast and other cancer types through IHC, helping you to predict potential responses to targeted therapies.
Learn more: https://bit.ly/3U6YlO3
Our TROP2 Recombinant Antibody can be used to map TROP2 expression in breast and other cancer types through IHC, helping you to predict potential responses to targeted therapies.
Learn more: https://bit.ly/3U6YlO3
#TissueTuesday
Our CD117 Recombinant Antibody has been validated for positive IHC detection in GIST tissue and can be used to identify these tumors with broad confidence in sarcoma research models.
Learn more:
https://bit.ly/3STVU0F
Our CD117 Recombinant Antibody has been validated for positive IHC detection in GIST tissue and can be used to identify these tumors with broad confidence in sarcoma research models.
Learn more:
https://bit.ly/3STVU0F
July 14, 2026 at 6:59 PM
#TissueTuesday
Our CD117 Recombinant Antibody has been validated for positive IHC detection in GIST tissue and can be used to identify these tumors with broad confidence in sarcoma research models.
Learn more:
https://bit.ly/3STVU0F
Our CD117 Recombinant Antibody has been validated for positive IHC detection in GIST tissue and can be used to identify these tumors with broad confidence in sarcoma research models.
Learn more:
https://bit.ly/3STVU0F
#TissueTuesday, we’d like to put the spotlight on our new p120 Catenin Recombinant Antibody 💡
Our p120 catenin Recombinant Antibody can be used in IHC to visualize translocation events in colon cancer tissue.
Learn more: https://bit.ly/4g7kGE1
Our p120 catenin Recombinant Antibody can be used in IHC to visualize translocation events in colon cancer tissue.
Learn more: https://bit.ly/4g7kGE1
June 30, 2026 at 3:02 PM
#TissueTuesday, we’d like to put the spotlight on our new p120 Catenin Recombinant Antibody 💡
Our p120 catenin Recombinant Antibody can be used in IHC to visualize translocation events in colon cancer tissue.
Learn more: https://bit.ly/4g7kGE1
Our p120 catenin Recombinant Antibody can be used in IHC to visualize translocation events in colon cancer tissue.
Learn more: https://bit.ly/4g7kGE1
#TissueTuesday
ACPP is a tyrosine phosphatase that helps to dephosphorylate growth promoting receptors such as HER2. As such, its expression is often decreased in prostate cancer cells, allowing them to proliferate uncontrollably.
Learn more: https://bit.ly/4etopdL
ACPP is a tyrosine phosphatase that helps to dephosphorylate growth promoting receptors such as HER2. As such, its expression is often decreased in prostate cancer cells, allowing them to proliferate uncontrollably.
Learn more: https://bit.ly/4etopdL
June 9, 2026 at 5:04 PM
#TissueTuesday
ACPP is a tyrosine phosphatase that helps to dephosphorylate growth promoting receptors such as HER2. As such, its expression is often decreased in prostate cancer cells, allowing them to proliferate uncontrollably.
Learn more: https://bit.ly/4etopdL
ACPP is a tyrosine phosphatase that helps to dephosphorylate growth promoting receptors such as HER2. As such, its expression is often decreased in prostate cancer cells, allowing them to proliferate uncontrollably.
Learn more: https://bit.ly/4etopdL
#TissueTuesday
The absence of DAZL expression is often correlated with tumor recurrence and increased aggressiveness of testicular cancers. As such, DAZL antibodies can be used in IHC experiments to identify and differentiate between various testicular tumor types.
👉 https://bit.ly/49DUmx8
The absence of DAZL expression is often correlated with tumor recurrence and increased aggressiveness of testicular cancers. As such, DAZL antibodies can be used in IHC experiments to identify and differentiate between various testicular tumor types.
👉 https://bit.ly/49DUmx8
May 19, 2026 at 3:06 PM
#TissueTuesday
The absence of DAZL expression is often correlated with tumor recurrence and increased aggressiveness of testicular cancers. As such, DAZL antibodies can be used in IHC experiments to identify and differentiate between various testicular tumor types.
👉 https://bit.ly/49DUmx8
The absence of DAZL expression is often correlated with tumor recurrence and increased aggressiveness of testicular cancers. As such, DAZL antibodies can be used in IHC experiments to identify and differentiate between various testicular tumor types.
👉 https://bit.ly/49DUmx8
#TissueTuesday
We’re spotlighting our MUC1 Recombinant Antibody, in honor of colorectal cancer awareness month.
Our MUC1 Recombinant Antibody can be used in chromogenic IHC experiments to study tumor progression in colon and rectal tissues.
Learn more: https://bit.ly/4rMLIUg
We’re spotlighting our MUC1 Recombinant Antibody, in honor of colorectal cancer awareness month.
Our MUC1 Recombinant Antibody can be used in chromogenic IHC experiments to study tumor progression in colon and rectal tissues.
Learn more: https://bit.ly/4rMLIUg
March 10, 2026 at 4:55 PM
#TissueTuesday
We’re spotlighting our MUC1 Recombinant Antibody, in honor of colorectal cancer awareness month.
Our MUC1 Recombinant Antibody can be used in chromogenic IHC experiments to study tumor progression in colon and rectal tissues.
Learn more: https://bit.ly/4rMLIUg
We’re spotlighting our MUC1 Recombinant Antibody, in honor of colorectal cancer awareness month.
Our MUC1 Recombinant Antibody can be used in chromogenic IHC experiments to study tumor progression in colon and rectal tissues.
Learn more: https://bit.ly/4rMLIUg
#TissueTuesday
Our KEAP1 Uni-rAb, is a high-affinity recombinant antibody that has been validated for positive IHC signals in lung cancer tissue, allowing for seamless incorporation into your research model and high-confidence detection.
Learn more: https://bit.ly/3MuglhO
Our KEAP1 Uni-rAb, is a high-affinity recombinant antibody that has been validated for positive IHC signals in lung cancer tissue, allowing for seamless incorporation into your research model and high-confidence detection.
Learn more: https://bit.ly/3MuglhO
February 17, 2026 at 5:13 PM
#TissueTuesday
Our KEAP1 Uni-rAb, is a high-affinity recombinant antibody that has been validated for positive IHC signals in lung cancer tissue, allowing for seamless incorporation into your research model and high-confidence detection.
Learn more: https://bit.ly/3MuglhO
Our KEAP1 Uni-rAb, is a high-affinity recombinant antibody that has been validated for positive IHC signals in lung cancer tissue, allowing for seamless incorporation into your research model and high-confidence detection.
Learn more: https://bit.ly/3MuglhO
#TissueTuesday
We’d like to put a spotlight on our new Cytokeratin 8 Monoclonal Antibody!
Our Cytokeratin 8 Monoclonal Antibody has been optimized for use in IHC, making it an ideal reagent for tracking tumor progression in your cancer model.
ow.ly/XAft50XVLpA
We’d like to put a spotlight on our new Cytokeratin 8 Monoclonal Antibody!
Our Cytokeratin 8 Monoclonal Antibody has been optimized for use in IHC, making it an ideal reagent for tracking tumor progression in your cancer model.
ow.ly/XAft50XVLpA
January 13, 2026 at 5:00 PM
#TissueTuesday
We’d like to put a spotlight on our new Cytokeratin 8 Monoclonal Antibody!
Our Cytokeratin 8 Monoclonal Antibody has been optimized for use in IHC, making it an ideal reagent for tracking tumor progression in your cancer model.
ow.ly/XAft50XVLpA
We’d like to put a spotlight on our new Cytokeratin 8 Monoclonal Antibody!
Our Cytokeratin 8 Monoclonal Antibody has been optimized for use in IHC, making it an ideal reagent for tracking tumor progression in your cancer model.
ow.ly/XAft50XVLpA
Welcome to #TissueTuesday
This week we're putting a spotlight on one of our newest monoclonal antibodies for FOXP3. A key regulator of Treg cells, FOXP3 plays critical roles in maintaining T cell tolerance and preventing autoimmune diseases.
Learn more: ow.ly/UTHU50UKeco
This week we're putting a spotlight on one of our newest monoclonal antibodies for FOXP3. A key regulator of Treg cells, FOXP3 plays critical roles in maintaining T cell tolerance and preventing autoimmune diseases.
Learn more: ow.ly/UTHU50UKeco
January 21, 2025 at 4:07 PM
Welcome to #TissueTuesday
This week we're putting a spotlight on one of our newest monoclonal antibodies for FOXP3. A key regulator of Treg cells, FOXP3 plays critical roles in maintaining T cell tolerance and preventing autoimmune diseases.
Learn more: ow.ly/UTHU50UKeco
This week we're putting a spotlight on one of our newest monoclonal antibodies for FOXP3. A key regulator of Treg cells, FOXP3 plays critical roles in maintaining T cell tolerance and preventing autoimmune diseases.
Learn more: ow.ly/UTHU50UKeco
Today's #TissueTuesday involves autopsy findings in a cat:
❓Key histopath feature
❓Cause
Check out the entire case in #VetPath via the Q&A links below!
Q:👉bit.ly/4kYzSmw
A:👉bit.ly/44c4I3J
❓Key histopath feature
❓Cause
Check out the entire case in #VetPath via the Q&A links below!
Q:👉bit.ly/4kYzSmw
A:👉bit.ly/44c4I3J
June 24, 2025 at 7:15 PM
Today's #TissueTuesday involves autopsy findings in a cat:
❓Key histopath feature
❓Cause
Check out the entire case in #VetPath via the Q&A links below!
Q:👉bit.ly/4kYzSmw
A:👉bit.ly/44c4I3J
❓Key histopath feature
❓Cause
Check out the entire case in #VetPath via the Q&A links below!
Q:👉bit.ly/4kYzSmw
A:👉bit.ly/44c4I3J